Chinese biotech shares are surging this year on growing optimism over innovative cancer treatments being licensed to western ...

This is an audio transcript of the FT News Briefing podcast episode: ‘Big Pharma markets left in a ‘patent cliff’-hanger’ ...

After Trump's announcement, Commerce Secretary Howard Lutnick told CNBC that details on pharmaceutical tariffs would come at ...

However, yesterday’s shock twist out of Washington could test just how tough Big Pharma really is, with health care stocks ...

Today’s settlement brings in millions of dollars to help Utah heal from this epidemic and ensures families see the justice ...

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Yahoo Finance Senior Reporter Anjalee Khemlani joins Morning Brief to discuss Merck's (MRK) pending $10 billion acquisition ...

Methode Electronics posted adjusted loss of 77 cents per share, missing market estimates of earnings of 4 cents per share, ...

Indian drugmaker Anthem Biosciences' ANTH.NS $395 million public listing was fully subscribed on the second day of bidding, as investors bet on the company's growth prospects at a time when global big ...

Big Data enables pharma companies to make these data-driven decisions throughout the planning, implementation and evaluation process of operations across the organisation, empowering them to ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

The House passed the “One Big Beautiful Bill Act” on July 3, which includes sweeping changes to healthcare and some pharma-related provisions.